Nurse Practitioner, Family · Rancho Cucamonga, CA
NPI
1760134852
Since 2022
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
9170 Haven Ave Ste 120
Rancho Cucamonga, CA, 91730
Phone (909) 476-8700
Groups this clinician bills Medicare through
Medicare paid, 2022
$12K
193 services
Medicare patients, 2022
47
Average age 77
Drug cost, 2024
$2.3M
5,112 prescriptions
Company payments, 2025
$2,533
From 20 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Nancy S Meng was code 99309 (snf e&m), 123 times for 38 patients. In total Nancy S Meng billed 193 services in 9 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 123 | 38 | $62.71 | $7,713 |
| 99305 SNF E&M | Facility | 26 | 26 | $89.99 | $2,340 |
| 99497 Care Management/Coordination | Facility | 16 | 16 | $54.54 | $873 |
Medicare prescription drug claims, 2024
In 2024, the drug Nancy S Meng prescribed most often to Medicare patients was Levothyroxine Sodium, with 434 prescriptions and refills. In total Nancy S Meng wrote 5,112 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 434 | 1,076 | 132 | $4,810 |
| Ozempic Semaglutide | 386 | 468 | 97 | $431K |
| Trulicity Dulaglutide | 374 | 459 | 76 | $428K |
| Metformin Hcl Generic | 283 | 752 | 103 | $1,946 |
| Farxiga Dapagliflozin Propanediol | 266 | 438 | 79 | $231K |
| Jardiance Empagliflozin | 217 | 352 | 59 | $199K |
| Mounjaro Tirzepatide | 211 | 222 | 34 | $223K |
| Atorvastatin Calcium Generic | 193 | 436 | 68 | $1,449 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 129 | 247 | 43 | $17K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 97 | 204 | 28 | $89K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 87 | 143 | 24 | $40K |
| Humalog Kwikpen U-100 Insulin Lispro | 83 | 161 | 29 | $25K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 81 | 172 | 36 | $7,424 |
| Pravastatin Sodium Generic | 80 | 202 | 29 | $674 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 74 | 123 | 18 | $18K |
Brand drugs: 2,850 claims; generic drugs: 1,962 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nancy S Meng $2,533 ($2,533 in general payments such as food, travel and fees) from 20 companies. The largest payer was Becton, Dickinson and Company with $875.
| Company | Payments | Amount |
|---|---|---|
| Becton, Dickinson and Company BDX | 1 | $875 |
| Abbott Laboratories ABT | 13 | $428 |
| Novo Nordisk Inc NVO | 8 | $175 |
| Radius Health, Inc. | 7 | $171 |
| Amgen Inc. AMGN | 9 | $162 |
| Lilly USA, LLC LLY | 6 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $96.8 |
| Recordati_rare_diseases_inc. | 3 | $87.49 |
| Madrigal Pharmaceuticals MDGL | 2 | $58.84 |
| Dexcom, Inc. DXCM | 2 | $51.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.